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Summary
Objective: Review the literature for single site cartilage defect research and evaluate the respective strengths and weaknesses of different
preclinical animal models.
Method: A literature search for animal models evaluating single site cartilage defects was performed. Variables tabulated and analyzed in-
cluded animal species, age and number, defect depth and diameter and study duration. Cluster analyses were then used to separate animals
with only distal femoral defects into similar groups based on defect dimensions. Representative human studies were included allowing com-
parison of common clinical lesions to animal models. The suitability of each species for single site cartilage defect research and its relevance
to clinical human practice is then discussed.
Results: One hundred thirteen studies relating to single site cartilage defects were reviewed. Cluster analysis included 101 studies and placed
the murine, laprine, ovine, canine, porcine and caprine models in group 1. Group 2 contained ovine, canine, porcine, caprine and equine
models. Group 3 contained only equine models and humans. Species in each group are similar with regard to defect dimensions. Some spe-
cies occur in multiple groups reﬂecting utilization of a variety defect sizes. We report and discuss factors to be considered when selecting
a preclinical animal model for single site cartilage defect research.
Discussion: Standardization of study design and outcome parameters would help to compare different studies evaluating various novel ther-
apeutic concepts. Comparison to the human clinical counterpart during study design may help increase the predictive value of preclinical
research using animal models and improve the process of developing efﬁcacious therapies.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) has signiﬁcant impact on the health care
system. An estimated 9% of the United States population
aged 30 and older have clinical OA1. Cartilage has limited
healing capacity and as a result injury of the articular sur-
face may lead to OA. Focal trauma causing defects in the
cartilage surface is repaired with tissue that is commonly in-
ferior to the original cartilage. The extent to which the new
tissue resembles cartilage is determined by the species,
age, size of the defect and its anatomic location. This infe-
rior repair tissue may subsequently lead to OA. Various joint
resurfacing treatments for focal traumatic events affecting
the articular surface are available including debridement
techniques, osteochondral transplants, or novel replace-
ment devices2e8. Animal models in research are widely
used to evaluate novel concepts for regenerative joint
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705The average human defect is approximately 550 mm3
in volume9,10 and 95% of defects involve cartilage with-
out affecting the subchondral bone9. A perfect animal
model would precisely mimic the human. This has
been difﬁcult to produce11. Historically and indeed cur-
rently the role spontaneous regeneration of single site
cartilage defects plays in the ultimate success of a study
is a concern. Examples of spontaneously healing carti-
lage defects in ponies have been described by Convery
et al. and in rabbits by Salter et al. in the late 1970s and
early 1980s. Evidently consideration of the beneﬁts and
limitations of the available animal models given that no
perfect preclinical animal model currently exists is
important.
The purpose of this review was to evaluate preclinical
animal models relating to single site cartilage defect
research and to present comparisons between species.
Furthermore to allow for an easy reference regarding com-
monly utilized species, animal numbers, defect location,
defect dimensions and commonly considered critical sized
defects. This could greatly improve the process of suc-
cessfully bringing technologies from the bench to bed-
side and allow for more effective comparison between
studies.
706 B. J. Ahern et al.: Preclinical animal models in single site cartilage defect testingMethods
A search using PubMed and Web of Science for preclinical animal models
evaluating single site cartilage defects was performed. The following key-
words were used: murine-, laprine-, canine-, ovine-, caprine-, porcine-, and
equine-model, human, OA, arthritis, osteochondral, chondral, subchondral,
cartilage, resurfacing, repair, defect, animal model. The reference sections
of the included studies were also screened. Original research utilizing animal
models for single site chondral/osteochondral defect repair in diarthrodial
joints of the appendicular skeleton from 1990 to 2007 was included. Informa-
tion pertaining to the age, number and species of animals utilized, defect di-
mensions and location and study duration were tabulated. The age of
skeletal maturity and the dimension of commonly recognized critical size de-
fects for each species and the different mechanical loading environments
were considered and discussed.
Studies involving the distal femora were isolated. Standard cartilage thick-
ness for the medial femoral condyle was obtained from work by Frisbie
et al.12. This is the only reference in the current literature reporting compar-
ative values for cartilage thickness between species using a standardized
technique. These values were used to calculate the chondral and subchon-
dral components. Studies were then objectively assembled into substrata
comprising ‘groups’ of ‘similar’ species, based upon cartilage thickness, de-
fect depth and diameter. To achieve this we used cluster analyses following
the methods outlined in Everitt et al.13. We employed k means clustering with
from two to ﬁve clusters and, based on Milligan’s study14 we used Calin-
ski’s15 stopping rule for selection of the optimal number of clusters, in this
case three. Stata version 10.0 was used for all cluster analyses.Results
The literature review returned 113 published studies. In-
formation pertaining to the number of studies performed,
animal numbers utilized, total defect volume, proportional
chondral and subchondral defect volumes are presented
in Table I. This information is further presented in Figs. 1
and 2 comparing the animal data to human clinical data.
Figure 1 differentiates the overall defect volume into the
subchondral and chondral components. Figure 2 presents
the relative proportions of the defects as a percentage of
the total volume. A comparison between the cartilage vol-
umes of commonly reported critical sized defect lesions is
compared to the average reported defect cartilage compo-
nent in Fig. 3.CLUSTER ANALYSISStatistical cluster analysis was applied to all of the studies
with respect to total defect volume, defect diameter and car-
tilage depth. Six studies reporting common human distal
femoral defects were utilized allowing humans to be included
in the analysis. A total of 101 studies involved were suitable
for inclusion. Cluster analysis separated these studies into
three groups. Group 1 consisted of a majority of the research
studies and involved models with similar proportioned small
defects (Table II). Group 2 consisted of mostly medium and
large sized animals, predominantly goats and horses. Group
3 contained horses and humans only. The mean, standard
deviation and 25, 50 and 75% conﬁdence intervals for
each cluster group are presented in Table III.
Rodent
The murine model is predominately used in the early
stages of biomaterial testing. It is a common ﬁrst in vivo ex-
periment to provide proof-of-concept data. A majority of
studies involve heterotopic chondrogenesis models im-
planting biomaterials sub-cutaneously in the back1,3,16e25
or intra-muscularly19,26. However, articular defect models
have been used in a limited number of cases27e31.
Rodents are easy to handle and require limited spe-
cialty logistics rendering this model economicallypractical. On average 30 rodents have been studied to
a 10 weeks endpoint (range 4e24). Rodents are difﬁcult
surgical models for cartilage defect testing as the growth
plates do not close, they have very small joints and ex-
tremely thin cartilage (3e5 cells thick)32. This animal
model is limited to very small defects (Table I and
Fig. 1). Further, when used, a large proportion of the de-
fect involves the subchondral bone (Fig. 2). It is extremely
difﬁcult to produce a surgical cartilage defect model in the
rodent that is suitable for comparison to the human
situation.
Rabbit
Many studies have utilized the laprine model for the
evaluation of cartilage defect therapy. They are relatively
inexpensive, require simple husbandry, reach early skele-
tal maturity at 9 months4 and have a long track record of
biomedical research. A 3 mm diameter has been consid-
ered the critical sized defect to prevent spontaneous
healing4,33,34. This dimension is questionable due to re-
ported spontaneous healing. Larger defects of 4 and
5 mm diameter are probably a more suitable sized de-
fect35,36. The cartilage thickness in the medial femoral
condyle of rabbits is approximately 0.3 mm thick12. The
most common defect depth utilized is 3 mm37e40. Resul-
tantly 90% of the defect volume involves the subchondral
bone (Figs. 1 and 2).
A broad range of defect dimensions have been used re-
sulting in a large standard deviation of defect volume (Table
I). Whilst the cartilage component is similar within studies,
the amount of subchondral bone defect volume is highly
variable. This large difference in the exposure to the sub-
chondral bone could be a source for variability in results.
Thus comparison between studies is difﬁcult.
Defects have been created in the femoral troch-
lea16,33,38e52, the medial femoral condyle37,53 and the lat-
eral femoral condyle53. The femoral trochlea is a partial
weight bearing location32. Due to the acute angulation of
the laprine knee, their relatively light bodyweight (range
2e4.5 kg) and the use of partial weight bearing surfaces,
the loading conditions are signiﬁcantly less than in large
animal models. As a result they are less stringent evalua-
tions of cartilage repair.
The age of rabbits used ranges from 9 to 36 weeks. The
age of skeletal maturity in rabbits is from 16 to 39 weeks of
age4,54. Young and adolescent rabbits of up to 20 weeks
have shown remarkable spontaneous cartilage regenera-
tion55,56 with normal hyaline cartilage present in control de-
fects by 12 weeks post-surgery37. As a consequence in
research utilizing young and adolescent rabbits the degree
of regeneration attributable to intrinsic healing must be
considered.
Researchers have followed the various laprine defect
models for an average of 16 weeks (range 2e76). This
short endpoint means that the long-term efﬁcacy of a treat-
ment is not assessed. The median number of rabbits used
per study was 33 with a range of 6e210. The option to use
large numbers of phenotypically similar subjects is a beneﬁt
of this animal model in comparison to other animal
models57.
Cluster analysis placed all laprine models in group 1.
Care must be taken during study design using this model
and in interpretation of results due to potential spontaneous
healing and unique weight bearing conditions. However,
with due consideration the rabbit is a model which is useful
in evaluation of early phases of a therapy.
Table I
Overview of literature with reference to study cohort size, defect volume (mm3) and cartilage thickness (mm). Cartilage thickness of the medial
femoral condyle from Frisbie et al.12. Defect volumes were calculated for cylindrical shaped defects using V¼ pr2h, for cube shaped defects
using V¼ lwh (r¼ radius, h¼ depth, l¼ length and w¼width of the cartilage defect)
Species Medial femoral
condyle cartilage thickness (mm)
Studies
performed
Animal number
utilized
Total
volume (mm3)
Cartilage
volume (mm3)
Subchondral
volume (mm3)
Murine 0.1 5 Mean 30 2.17 0.12 2.05
SD 15.88 2.85 0.06 2.81
Mode 30 5.3 0.18 0
Laprine 0.3 39 Mean 18.86 53 7.15 45.86
SD 11.57 54.64 13.35 52.78
Mode 16 21.21 2.12 19.09
Ovine 0.45 13 Mean 23.69 359.54 18.03 341.51
SD 15.74 683.35 19.97 663.79
Mode 20 n/a 12.5 0
Canine 0.95 16 Mean 34.82 82.39 18.43 63.86
SD 46.85 197.94 17.4 181.9
Mode 8 11.94 11.94 0
Porcine 1.5 10 Mean 9.56 107.43 43.76 63.67
SD 2.35 87.87 24.05 78.9
Mode 10 183.22 34.35 0
Caprine 1.1 13 Mean 30.55 251.65 45.71 63.67
SD 20.39 448.46 35.1 78.9
Mode 50 31.1 17.49 0
Equine 1.75 17 Mean 9 334.73 192.67 142.06
SD 2.03 237.87 94.21 213.08
Mode 8 137.44 137.44 0
Human 2.35 n/a Mean n/a 552.25 552.25 0
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Studies involving the dog are subjected to intense scru-
tiny because of their companion animal status. With other
animal models available, cartilage defect research in the
dog has been limited as a result. The cartilage thicknessMean Defe
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Fig. 2. Chondral and subchondral components of the preclinical animal model defects as a percentage of the total defect compared to the
human patient.
708 B. J. Ahern et al.: Preclinical animal models in single site cartilage defect testingThe average cartilage volume of these defects is consid-
erably less than reported human defects3,10 (Fig. 1). An ex-
tremely large defect of 10 mm diameter and 10 mm depth
used by van Dyk in 1998, produced a cartilage defect vol-
ume of 55 mm3 considerably smaller than the average hu-
man lesion10. Furthermore, a large proportion of defects
involve the subchondral bone which is another important
difference (Fig. 2).
A beneﬁt is that arthroscopic evaluation of the knee joint
is feasible. Allowing macroscopic visualization and biopsy
of defects during the course of research without requiring
necropsy63.Comparative cartilage
sized defects and r
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Fig. 3. A comparison of the cartilage volume of critical sized defects to th
thickness cartilagDefects have been located in the femoral troch-
lea58,59,62e65, the medial femoral condyle61 and both con-
dyles concurrently60,66.
A difﬁculty with the canine model is obtaining consistent
skeletally mature subjects. This is probably because by
the age of skeletal maturity at 12e24 months of age4
most humaneanimal bonds are very strong. The median
age was 41 months (range 18e72). A median of 29 dogs
has been operated (range 25e30). The average endpoint
was 16 weeks (range 2e78).
Cluster analysis placed all but the van Dyk canine study
in group 1. This demonstrates that unless extremely large volumes of  critical
eported averages
Caprine Porcine Equine
Critical sized
defect
Average
reported studies
e average reported cartilage defect volume assuming both are full
e defects.
Table II
Cluster analysis utilized to group studies with relation to similarities
in cartilage thickness, defect diameter and volume
Species Group Total
1 2 3
Murine 5 5
Laprine 27 27
Ovine 9 1 10
Canine 14 1 15
Porcine 6 2 8
Caprine 9 4 13
Equine 1 10 6 17
Human 6 6
709Osteoarthritis and Cartilage Vol. 17, No. 6defects are created the canine model is mostly a small de-
fect model.
The dog is a reasonable model for preclinical testing with
regard to its ability to have defects involving only the carti-
lage, the option of second look arthroscopy, similar anat-
omy and weight bearing conditions. In addition, dogs are
easily trainable on treadmills and therefore the canine
model is suitable for exercising studies. However, due to
relatively small defect volumes and ethical reasons it is
not a widely utilized species.
Sheep
The sheep is a commonly utilized animal model as they
are readily available, easy to handle and are relatively inex-
pensive. In addition the anatomy of the knee is similar to hu-
mans. ‘‘Second look’’ arthroscopy is possible which is
beneﬁcial. However, due to a large fat pad and the degree
of ﬂexion required to visualize the femoral condyles this pro-
cedure requires a skilled arthroscopist.
Sheep have articular cartilage that is of variable thick-
ness. Lu states that the cartilage ranges from 0.4 to
1 mm67, Frisbie reports 0.45 mm and reference texts sug-
gest 1.68 mm as an average thickness for the medial fem-
oral condyle4,12,32,67. This variability makes the defect
volume involving the cartilage and the subchondral bone
likely to be different between individual subjects. This could
produce variable results within a study. Defects have varied
widely in the volume of cartilage and subchondral bone in-
volvement67e74. Therefore, the standard deviation betweenTable III
Cluster analysis groups demonstrating means, standard deviations
and p25, 50, 75 confidence intervals for thickness, diameter and
volume between the 3 groups
Group Mean p25 p50 p75 SD
1 Thickness 0.66 0.30 0.45 0.95 0.44
Diameter 4.30 3.00 4.00 5.40 1.59
Volume 12.37 2.89 7.16 17.50 12.50
2 Thickness 1.46 1.10 1.75 1.75 0.39
Diameter 10.11 10.00 10.00 10.00 1.64
Volume 114.31 79.52 130.93 137.44 35.49
3 Thickness 2.05 1.75 2.05 2.35 0.31
Diameter 16.79 15.00 15.68 17.55 2.85
Volume 496.15 309.25 401.38 586.25 254.50
Total Thickness 0.97 0.03 0.95 1.50 0.66
Diameter 6.82 4.00 5.00 10.00 4.64
Volume 88.02 3.77 15.11 79.52 177.83published studies is large. This limits the ability to draw
comparisons between ovine studies.
Pearce used a very large defect of 15 mm diameter in
200175. A defect of this diameter can produce a cartilage
defect volume of 170 mm3, which is a similar volume to
the lower range of human defects9,10. The large cartilage
defects created in the sheep are associated with large total
defect volumes (Fig. 1). Additionally, these defects produce
a large proportion (>90%) in the subchondral bone (Fig. 2).
Another disadvantage is the very dense and hard subchon-
dral bone. This often prevents reproducible bone defect us-
ing trephine and fracture techniques without requiring
drilling of the defect. This limits the choices of experimental
design, especially for therapies requiring a healthy bleeding
subchondral bone bed.
Cluster analysis placed all except one study in group 1
despite sheep having relatively large total defect volume be-
cause the cartilage volume was still comparatively low.
The average cartilage defect used in distal ovine femora
has been 7.4 mm in diameter (range 2e15). The critical size
defect has been reported as 7 mm4. The location of the car-
tilage defects in the ovine model has involved the medial
femoral condyle68,72,75e77, both femoral condyles70,71,78
and the femoral trochlea69. On average 18 (range 4e40)
sheep have been enrolled with an endpoint of 21 weeks
(range 2e78).
Skeletal maturity is at 2e3 years of age. In the literature,
sheep are commonly referred to as mature without an age
being stated.
In conclusion, the sheep is a readily accessible model for
cartilage defect testing. However, owing to it’s variability in
cartilage thickness and an often large subchondral defect
component and relatively late skeletal maturity it is a model
with some limitations.
Goat
The goat is a commonly utilized model. The femoro-tibial
joint allows for ‘‘second look’’ arthroscopic examination79,
has thick cartilage, and a joint anatomy similar to humans.
The cartilage thickness has been reported as 0.8, 1.1, 1.2
and 2 mm thick for the medial femoral condyle79. This vari-
ability likely results in variations of the volume of cartilage
and subchondral bone defects within studies. A beneﬁt of
the cartilage thickness in this species is the allowance for
partial and complete thickness defects as desired. This op-
tion is not possible in smaller animal models. Published
studies have mostly created osteochondral defects. As pre-
viously mentioned, 95% of human cartilage defects do not
involve the subchondral bone, as a result the ability to pro-
duce partial thickness defects is of importance as it more
closely resembles the human9,50. The subchondral bone
is softer when compared to sheep and common surgical
techniques to create osteochondral defects can be readily
and successfully applied.
The proportions of cartilage and subchondral bone in-
volvement in goats are closer to the human situation than
previously mentioned models (Fig. 2). Cartilage defects of
150 mm3 can be produced by a 12 mm diameter defect. De-
spite this still being in the lower range of common human
cartilage defects, these defects may allow cautious correla-
tion between caprine trial conclusions and possible human
expectations. As a result the goat is suitable to model small
sized cartilage defects. On the other hand a limitation of
published studies is the utilization of defects with large sub-
chondral components which is considerably different to the
human (Fig. 1).
710 B. J. Ahern et al.: Preclinical animal models in single site cartilage defect testingCartilage defect diameters range from 4.5 to 12 mm. The
most frequently reported defect diameter is 6 mm20,56,79e88.
Cartilage defects of 3 mm diameter have been reported to
heal spontaneously81. A critical defect size of 6 mm does
not heal after 6 months86.
Cartilage defects have involved the lateral56,86 and me-
dial femoral condyles80e85,87e90, and trochlear
groove79,80,82,85. The average number of animals used
was 14 (range 6e32) and an average age of 35 months
(range 18e72). Goats have commonly been followed to
an endpoint of 26 weeks (range 2e104).
Skeletal maturity is similar to sheep at 2e3 years of age
and husbandry requirements and cost are also comparable.
The goat is a relatively robust and ﬂexible animal model
commonly used for small cartilage defect trials.
Pig
The pig is a not a commonly used model for cartilage de-
fect research. This is due to their large size, handling difﬁ-
culties and involved logistical requirements in housing
pigs. These problems can be slightly ameliorated by the se-
lection of minipigs which are commonly utilized. A potential
beneﬁt of using pigs is their cartilage thickness. Chiang and
Frisbie have reported the cartilage to be 1.5 mm and
Hembry 2.0 mm thick in the medial femoral condyle12,73,91.
This allows for the production of partial or full thickness de-
fects as required. This feature has been utilized to study
partial thickness cartilage defect therapies92. Despite the
large cartilage thickness of pigs, historically, the total defect
volume has not been as large as some other animal models
(Fig. 1). It is important to note however that defects created
often have a large portion of the defect involve only the car-
tilage. As a result the proportions of these defects are closer
to the human defect dimensions when compared to previ-
ously discussed models (Fig. 2).
An average of 24 pigs were utilized (range 11e57)73,91,92
and followed to an endpoint of 20 weeks (range 1e52) at an
average age of 57 weeks (range 12e234 weeks). The FDA
states that minipigs reach skeletal maturity by 42e52
weeks. Research by Vasara has reported that immature
pigs spontaneously repair 6 mm cartilage defects92. In adult
pigs a critical sized defect of 6 mm is supported from work
by Harman et al. in 200693. It is important that defect models
in pigs be undertaken in adult animals to minimize sponta-
neous cartilage healing. Lesions have been created in the
trochlear groove91,92,94,95, medial femoral condyle91 and
both femoral condyles73,96,97. The pig has a large cartilage
thickness for experimentation but researchers must con-
tend with animal housing, size and handling difﬁculties
which are less of a problem with other animal models.
Horse
The horse is the largest model available. The horse is
a companion animal and as a result ethical issues are a fac-
tor. The horse requires large facilities for both housing and
surgery, greater technical skills and equipment are also re-
quired that are not commonly available. Horses are typically
not bred for biomedical research use and it is therefore dif-
ﬁcult to obtain large numbers for a homogenous study co-
hort without considerable expense. Horses retiring from
various athletic careers are often available but require
screening for pre-existing musculoskeletal disease. On
the other hand, because the horse is a long lived and ath-
letic animal, it makes an appealing model to evaluate resur-
facing technologies in chronic defects. Additionally theavailability of post-operative exercise allows for evaluation
of repair under rigorous loading conditions.
The cartilage thickness of the horse is approximately
1.75e2 mm for the medial femoral condyle12,32. This carti-
lage thickness is similar to a human cartilage thickness of
2.2 mm32,98. Because the horse is an athlete presenting
clinically with a wide gamut of joint degeneration consistent
with OA, it has spawned a vast amount of basic and clinical
research addressing joint health. This is signiﬁcant when
considering assessment of outcome parameters. Most state
of the art in vitro biochemical, molecular, gene therapeutic
and immunohistochemical assays have been described
for the various equine joint tissues and ﬂuid99e115.
The large size of the horse allows for ‘‘second look’’ arthro-
scopic examination, and the cartilage thickness allows for the
production of partial or full thickness defects. This ﬂexibility is
not commonly available in other species. Defects can be pro-
duced that are of a size andproportion thatmost closely reﬂect
the human situation (Figs. 1 and 2)101e105,107e111,113e118. Fur-
thermore equine studies have historically involved cartilage
defects that are considerably higher than what is considered
the critical sized defect (Fig. 3). Cartilage defects in excess
of 350 mm3 with no subchondral bone involvement can be
produced. Of the discussed animal models, this is most simi-
lar, to human cartilage defects (Fig. 2). As a result the horse
was the only species to be placed in group 3 with humans
by cluster analysis (Table II). This being the case the horse
is the only animal model in which defect dimensions relevant
to human clinical practice can be produced. Defects have
ranged from 8 to 15 mm in diameter. The critical sized defect
has been reported as 9 mm4.
The horse is a large animal with an average weight of
400e500 kg. This weight places defects under stringent
loading conditions during and following anesthetic recovery.
While the horse provides a model in which defect dimen-
sions can correlate to the human clinical scenario, the load-
ing environment is of signiﬁcant concerns. Despite stall
conﬁnement, the static continuous loading of weight bearing
portions in the joints cannot be minimized as for a human
patient. Anatomical selection of the defect site is therefore
critical and it is important to have realistic expectations for
results from a device subjected to such considerable loads.
The lateral trochlea of the femur is the most common
location for cartilage defects101e105,107. Defects have also
been created in the lateral condyle of the metacarpophalan-
geal joint117 and the middle carpal bones108. A median of 8
horses has been used in each study with a range of 6e12
and followed to an endpoint of 19 weeks (range 2e52).
The average age was 46 months with a range of 12e72.
While the horse is certainly the most appealing animal
when it comes to size of joint anatomy and cartilage mor-
phology, the rigorous loading environment must be carefully
considered when designing a study.Discussion
There are many animal models that are used in cartilage
defect research. Large animal models such as the goat or
the horse may more closely resemble the human compared
to smaller animal models such as rodents or rabbits. But, it
is usually not ﬁscally feasible or practical to conduct initial
experiments in larger species. Therefore, it is generally
well accepted to choose a small animal model for initial
lines of investigation. However, ﬁnal preclinical evaluation
of an articular cartilage reconstruction technique may re-
quire conﬁrmation in a large animal model.
711Osteoarthritis and Cartilage Vol. 17, No. 6The statistical comparison of defects involving the distal
femora performed in this study analyzed defects involving
both femoral condyles and the trochlear groove with respect
to volume and the relative proportions between species. Cal-
culation of the proportional cartilage to subchondral volume
was based on work by Frisbie et al.12. These values were uti-
lized as they are the only evaluation of cartilage thickness be-
tween species that uses the samemethodology. Differences
between the cartilage thickness between the femoral con-
dyles and the trochlear groovewere not considered in the sta-
tistical analysis as a majority of the defects involved the
medial femoral condyle and due to no published data using
consistent technique between sites and or species.
Studies involving small cartilage defects can be ade-
quately performed on canine, ovine, porcine or caprine
models as are supported by our comparative analyses.
The most stringent test of a single site defect therapy is
the equine model. This is a reﬂection of the horse’s larger
joint anatomy and morphology allowing for a larger defect
of proportions that is more reﬂective to the clinical human.
The equine is historically the least commonly utilized and
only recently is gaining broader interest.
The further understanding of the biomechanical proper-
ties of normal articular cartilage and the functional require-
ments for repaired articular cartilage will be critical for the
advancement of tissue engineering of articular cartilage.
In order to achieve these goals, new techniques to measure
the biomechanical properties of normal, degenerated and
engineered cartilage, including minimally invasive and
non-invasive techniques for in vivo measurement will have
to be developed. The standardization of these techniques
and the selection of the appropriate animal model will be
critical for a meaningful comparative evaluation of tissue-
engineering techniques.Conﬂict of interest
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